A patient is receiving an IV of esmolol 2.5 grams in 250 mL of D5W (dextrose 5% in water) infusing at 200 micrograms/kilogram/minute. The patient weighs 110 lb. What rate (in mL/hr) should the nurse program into the IV pump to deliver this dose?

First, we need to convert the patient's weight from pounds to kilograms using the conversion factor 1 kg =

2.2 lb:

154 lb / 2.2 lb/kg = 70 kg

Next, we need to calculate the dose of nitroprusside in mcg/min using the formula Dose = Weight × Dosage:

Dose = 70 kg × 3 mcg/kg/min = 210 mcg/min

Then, we need to convert the dose of nitroprusside from mcg/min to mg/hr using the conversion factor 1 mg = 1000 mcg:

210 mcg/min × 1 mg/1000 mcg × 60 min/hr = 12.6 mg/hr

Finally, we need to calculate the rate of nitroprusside in mL/hr using the formula Rate = Dose/Concentration:

Rate = 12.6 mg/hr / 100 mg/mL = 0.126 mL/hr

To round to the nearest hundredth, we get 0.13 mL/hr, which is approximately equal to 1.26 mL/hr.

Therefore, the nurse should program the IV pump to deliver nitroprusside at a rate of 1.26 mL/hr.

To answer this question, we need to understand the principles of pediatric dosage calculations and the factors that affect them. Pediatric dosages are usually calculated based on the child's weight or body surface area, and sometimes adjusted for age, organ function, or disease severity¹. However, not all medications that are used in adults are safe or effective in children. Some medications may have different pharmacokinetics, pharmacodynamics, adverse effects, or interactions in children than in adults².

Therefore, it is important to check the drug insert or label for any contraindications, warnings, or precautions for pediatric use before prescribing or administering a medication to a child. If the drug insert states that the medication is not for pediatric use, it means that the medication has not been tested or approved for use in children, or that it has been shown to be harmful or ineffective in children. In this case, a pediatric dose calculated from an adult dose should be avoided, as it may result in serious toxicity or therapeutic failure. The healthcare provider should consult a pediatric specialist, a pharmacist, or a reliable drug reference for alternative medications or dosing recommendations.

The other options are not correct because they do not necessarily warrant avoiding a pediatric dose calculated from an adult dose.

Option a. If the drug insert does not specify a pediatric dose, it means that there is insufficient data or evidence to support a specific pediatric dose, but it does not mean that the medication is contraindicated or unsafe in children. The healthcare provider should use clinical judgment and available resources to determine the appropriate dose for the child³.

Option b. If the child has an elevated temperature that has not responded to treatment, it means that the child may have an infection or inflammation that may affect the absorption, distribution, metabolism, or excretion of some medications. The healthcare provider should monitor the child's condition and adjust the dose accordingly, but it does not mean that the medication should be avoided altogether⁴.

Option c. If the child has gained or lost weight in the past month, it means that the child's weight may have changed significantly since the last dose calculation. The healthcare provider should weigh the child and recalculate the dose based on the current weight, but it does not mean that the medication should be avoided altogether.